Anxiety Screening in Annual Wellness Visit
GIA® delivers cognitive, depression, and anxiety screening at the annual wellness visit in 40 seconds via tablet or video — completing the AWV cognitive requirement and CPT 96127 behavioral screening in a single interaction, without consuming clinician face time. Results write back to the EHR for clinician review under 2 minutes.
Clinical diagnosis of anxiety disorders in primary care has a pooled sensitivity of 44.5% (95% CI 33.7–55.9%) — more than half of anxiety cases are missed at the encounter level (Olariu et al., Depression and Anxiety 2015; meta-analysis of 24 studies pooling 34,902 patients). When clinicians work without a diagnostic instrument, unassisted sensitivity falls to 30.5% (95% CI 20.7–42.5%). An estimated 19.1% of US adults experience an anxiety disorder in any given year, with lifetime prevalence at 31.1% (NIMH, citing the National Comorbidity Survey Replication; data collection 2001–2003). Atypical presentation — somatic complaints such as chest tightness or gastrointestinal distress, irritability, or restlessness rather than expressed worry — further reduces the reliability of standard self-report instruments, particularly the GAD-7, which was validated primarily in younger populations. Peer-reviewed speech biomarker research underlying GIA® reports AUC 0.884 for anxiety detection from natural conversation. CPT 96127 (brief emotional/behavioral assessment with scoring and documentation, per standardized instrument) provides the established billing mechanism for structured anxiety screening, including at the Medicare annual wellness visit.
The Medicare annual wellness visit requires detection of any cognitive impairment that the individual may have as a core element of the personalized prevention plan, under 42 CFR § 410.15. CMS does not mandate a specific instrument — clinicians are explicitly directed to “consider using brief cognitive tests.” GIA® delivers a 40-second speech-biomarker screening that fits inside the existing annual wellness visit workflow, capturing the cognitive-detection element plus depression and anxiety screening in a single patient interaction.
Why Anxiety goes undetected in annual wellness visit
The annual wellness visit is delivered by a primary-care physician, nurse practitioner, or physician assistant in a 25–45 minute encounter. Medical assistants gather vitals and history. The cognitive screening component competes with every other AWV element for visit time. Anxiety symptoms are often subtle, progressive, and easily attributed to other factors in this care environment.
CMS requires cognitive screening at every annual wellness visit but does not specify a tool — many practices skip the component or use unstandardized methods that may not survive survey
Annual wellness visit completion rates across primary care average well below the eligible Medicare population — most of the gap is time constraints, not patient unwillingness
The cognitive screening component, when positive, opens reimbursement for CPT 99483 (Cognitive Care Plan visit) — but only when documentation supports it
Depression and anxiety screening at the annual wellness visit are reimbursable under CPT 96127 (brief emotional/behavioral assessment, scored standardized instrument) — captured per administration
MIPS Promoting Interoperability category measures reward consistent screening-workflow integration across the practice's AWV population
How does GIA® screen for Anxiety in annual wellness visit?
GIA® meets the patient by video, voice, or landline — wherever they are in the annual wellness visit environment. The screening conversation takes 40 seconds and feels like a natural check-in, not a clinical assessment.
During the conversation, GIA® analyzes over 2,500 speech biomarkers — including vocal tremor, articulatory precision, prosodic patterns, and cognitive load indicators — alongside 436 visual data points from facial micro-expressions and body movement during video sessions.
Results are delivered to the clinician in under 2 minutes. Four data types write back to the EHR automatically: structured screening results with ICD-10 codes, clinician-ready medical notes, a full timestamped transcript, and the recorded patient video. The clinician reviews and submits — the human is always in the loop.
Anxiety in annual wellness visit: the numbers.
The screening challenge
The cognitive-detection element of the annual wellness visit competes for clinician face time against every other AWV requirement — health risk assessment, medical and family history, vitals, depression and substance-use screening, functional ability, fall risk, advance care planning. In a 25–45 minute encounter, most practices either skip the cognitive element, complete it with unstandardized direct observation, or document it pro forma. GIA® delivers the cognitive-detection element as structured, reviewable evidence without consuming clinician visit time. Documentation supports billing accuracy for G0438 / G0439; coding decisions remain with the clinical documentation and coding team.
What compliance requirements does this address?
G0438 (initial annual wellness visit) and G0439 (subsequent annual wellness visit) require documented cognitive screening as a core element. CPT 99483 (Cognitive Care Plan visit, 60 minutes) is separately reimbursable when a clinician documents cognitive impairment. CPT 96127 (brief emotional/behavioral assessment, scored standardized instrument) applies per administration to depression and anxiety screening, which GIA® supports alongside cognitive screening in the same 40-second interaction. Documentation supports billing accuracy; coding decisions remain with the clinical documentation and coding team.
GIA® produces structured documentation automatically — screening results with ICD-10 codes, clinician-ready medical notes, full timestamped transcripts, and recorded patient video — all written back to the EHR in real time and available for clinical, billing, and compliance review.
Anxiety screening in annual wellness visit
How is Anxiety screened in annual wellness visit?
GIA® screens for Anxiety through a single conversational interaction lasting 40 seconds. She analyzes over 2,500 speech biomarkers using Voice AI, Computer Vision, and Speech Biomarkers. GIA® delivers cognitive, depression, and anxiety screening at the annual wellness visit in 40 seconds via tablet or video — completing the AWV cognitive requirement and CPT 96127 behavioral screening in a single interaction, without consuming clinician face time. Results write back to the EHR for clinician review under 2 minutes. Results are delivered to the clinician in under 2 minutes.
Does Anxiety screening require additional staff?
No. GIA® conducts the screening conversation independently — zero additional clinical staff required during the interaction. The annual wellness visit is delivered by a primary-care physician, nurse practitioner, or physician assistant in a 25–45 minute encounter. Medical assistants gather vitals and history. The cognitive screening component competes with every other AWV element for visit time. The clinician reviews the results in under 2 minutes.
What is the accuracy of Anxiety screening?
Anxiety screening accuracy: AUC 0.884. The platform is peer-reviewed across 19 published studies and trained on 12.3 million longitudinal PAC/LTC patient records and 27 billion clinical events.
What does 42 CFR § 410.15 require for cognitive impairment detection at the annual wellness visit?
The regulation lists detection of any cognitive impairment as a required element of both the first and subsequent annual wellness visits. “Detection” is defined as assessment of an individual’s cognitive function by direct observation, with due consideration of information obtained by way of patient report or concerns raised by family, friends, or caretakers. CMS does not mandate a specific instrument — clinicians choose the method, and CMS guidance states “consider using brief cognitive tests.”
Which HCPCS codes apply to the annual wellness visit?
G0438 covers the initial annual wellness visit (one per beneficiary lifetime, no earlier than 12 months after Medicare Part B enrollment). G0439 covers subsequent annual wellness visits (one per 12-month period thereafter). Both require a documented personalized prevention plan that includes cognitive impairment detection.
How does GIA® support documentation for G0438 and G0439?
GIA® writes structured screening results, ICD-10 codes, clinician-ready medical notes, a full timestamped transcript, and the recorded patient video back to the EHR in real time. That documentation supports billing accuracy for the cognitive-detection element of G0438 or G0439. Coding decisions remain with the clinical documentation and coding team, and reimbursement determinations are made by the payer based on the complete documented encounter.
When during the annual wellness visit does GIA® screen the patient?
GIA® screens during rooming or in the waiting area before the clinician enters. The 40-second conversation produces results in under two minutes — typically before the clinician begins the face-to-face portion. The clinician reviews structured results during the visit instead of administering a separate cognitive instrument.
How does GIA® screen for anxiety?
GIA® analyzes 2,500+ speech biomarkers — including vocal tension, articulation rate, prosodic variability, and speech-pause patterns associated with anxious arousal — during a natural conversation lasting 40 seconds. Peer-reviewed biomarker accuracy for anxiety detection is AUC 0.884. Results write back to the EHR with structured notes for clinician review. A clinician reviews and approves every result before it enters the clinical record.
Why is anxiety underdetected in primary care?
A 2015 meta-analysis of 34,902 patients across 24 studies (Olariu et al., Depression and Anxiety) found pooled GP diagnostic sensitivity for anxiety disorders was 44.5% — more than half of cases were missed. Without a diagnostic instrument, unassisted sensitivity dropped further to 30.5%. Atypical presentation, somatic overlap that confounds the GAD-7, coexisting depression, and visit time constraints are commonly cited contributors.
How does GIA® support anxiety screening at the annual wellness visit?
Anxiety risk-factor review is not separately enumerated under 42 CFR § 410.15, but CPT 96127 (brief emotional/behavioral assessment with scoring and documentation, per standardized instrument) is the established billing code for structured anxiety screening — including when performed during the annual wellness visit alongside depression and cognitive-impairment elements. GIA® captures anxiety-associated speech biomarkers in the same 40-second screening that supports depression risk-factor review under § 410.15(a)(vi). Documentation writes back to the EHR for clinician review and supports billing accuracy; coding decisions remain with the clinical documentation and coding team.
Does GIA® diagnose anxiety?
No. GIA® screens — she does not diagnose. She surfaces structured risk signals from speech biomarker analysis for clinician review. The clinician applies clinical judgment, reviews additional data (history, current medications, functional and social context, coexisting conditions), and makes any diagnostic determination. GIA® is a clinical decision support tool with mandatory clinician-in-the-loop review on every result.
What is the limitation of standard anxiety screening tools in older adults?
Standard self-report tools — the GAD-7, HAM-A, and Beck Anxiety Inventory — include somatic items (heart racing, breathing difficulty, dizziness, restlessness) that overlap with cardiac, pulmonary, and other medical conditions common in older adults. In patients with cognitive impairment, self-report reliability drops further. Atypical anxiety presentations — physical complaints, irritability, or somatic preoccupation rather than expressed worry — further reduce sensitivity. GIA® analyzes speech biomarkers that do not depend on patient self-report style or insight.
Anxiety screening in other care settings
Other conditions screened in annual wellness visit
The Operator's Guide to Multimodal Clinical AI
What administrators, DONs, and regional operators need to know before evaluating clinical AI platforms. Covers EHR integration, staffing impact, reimbursement codes, and deployment timelines.